Literature DB >> 12089149

Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition.

Atsushi Enomoto1, Michael F Wempe, Hiroki Tsuchida, Ho Jung Shin, Seok Ho Cha, Naohiko Anzai, Akiteru Goto, Atsuhiko Sakamoto, Toshimitsu Niwa, Yoshikatsu Kanai, M W Anders, Hitoshi Endou.   

Abstract

l-Carnitine is an essential component of mitochondrial fatty acid beta-oxidation and plays a pivotal role in the maturation of spermatozoa within the male reproductive tract. Epididymal plasma contains the highest levels of l-carnitine found in the human body, and initiation of sperm motility occurs in parallel to l-carnitine increase in the epididymal lumen. Using a specific carrier, epididymal epithelium secretes l-carnitine into the lumen by an active transport mechanism; however, the structure-activity relationship comprising the carnitine-permeation pathway is poorly understood. We discovered a novel carnitine transporter (CT2) specifically located in human testis. Analyzing the primary structure of CT2 revealed that it is phylogenetically located between the organic cation transporter (OCT/OCTN) and anion transporter (OAT) families. Hence, CT2 represents a novel transporter family. When expressed in Xenopus oocytes, CT2 mediates the high affinity transport of l-carnitine but does not accept mainstream OCT/OCTN cationic or OAT anionic substrates. We synthesized and tested various carnitine-related compounds and investigated the physicochemical properties of substrate recognition by semi-empirical computational chemistry. The data suggest that the quaternary ammonium cation bulkiness and relative hydrophobicity be the most important factors that trigger CT2-substrate interactions. Immunohistochemistry showed that the CT2 protein is located in the luminal membrane of epididymal epithelium and within the Sertoli cells of the testis. The identification of CT2 represents an interesting evolutionary link between OCT/OCTNs and OATs, as well as provides us with an important insight into the maturation of human spermatozoa.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089149     DOI: 10.1074/jbc.M203883200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Organic and inorganic transporters of the testis: A review.

Authors:  David M Klein; Nathan J Cherrington
Journal:  Spermatogenesis       Date:  2015-01-07

Review 3.  Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.

Authors:  Atsushi Enomoto; Hitoshi Endou
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

Review 4.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

5.  Identification of a novel sodium-coupled oligopeptide transporter (SOPT2) in mouse and human retinal pigment epithelial cells.

Authors:  Paresh P Chothe; Santoshanand V Thakkar; Jaya P Gnana-Prakasam; Sudha Ananth; David R Hinton; Ram Kannan; Sylvia B Smith; Pamela M Martin; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-30       Impact factor: 4.799

Review 6.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

7.  Expression and analysis of two novel rat organic cation transporter homologs, SLC22A17 and SLC22A23.

Authors:  Katie M Bennett; Jun Liu; Courtney Hoelting; James Stoll
Journal:  Mol Cell Biochem       Date:  2011-02-27       Impact factor: 3.396

8.  A case of acute renal failure after exercise with renal hypouricemia demonstrated compound heterozygous mutations of uric acid transporter 1.

Authors:  Ayami Ochi; Takashi Takei; Akiko Ichikawa; Chiari Kojima; Takahito Moriyama; Mitsuyo Itabashi; Toshio Mochizuki; Atsuo Taniguchi; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2011-11-03       Impact factor: 2.801

9.  Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies.

Authors:  Sook Wah Yee; Dina Buitrago; Adrian Stecula; Huy X Ngo; Huan-Chieh Chien; Ling Zou; Megan L Koleske; Kathleen M Giacomini
Journal:  FASEB J       Date:  2020-10-30       Impact factor: 5.191

Review 10.  The SLC22 drug transporter family.

Authors:  Hermann Koepsell; Hitoshi Endou
Journal:  Pflugers Arch       Date:  2003-07-19       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.